Galecto Ownership
| GLTO Stock | USD 27.99 0.00 0.00% |
Shares in Circulation | First Issued 2017-12-31 | Previous Quarter 1.3 M | Current Value 1.3 M | Avarage Shares Outstanding 1.5 M | Quarterly Volatility 1.5 M |
Galecto Stock Ownership Analysis
About 13.0% of the company shares are owned by institutional investors. The company recorded a loss per share of 12.11. Galecto had not issued any dividends in recent years. The entity had 1:25 split on the 30th of August 2024. Galecto, Inc., a clinical-stage biotechnology company, develops molecules for the treatment of fibrosis, cancer, inflammation, and other related diseases. Galecto, Inc. was founded in 2011 and is based in Boston, Massachusetts. Galecto operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 40 people. To learn more about Galecto call the company at 45 70 70 52 10 or check out https://galecto.com.Besides selling stocks to institutional investors, Galecto also allocates a substantial amount of its earnings to a pull of share-based compensation to be paid out to its employees, managers, executives, and members of the board of directors. Share-Based compensation (also sometimes called Stock-Based Compensation) is a way of paying different Galecto's stakeholders with equity in the business. It is typically used as a motivation factor for employees to contribute beyond their regular compensation (salary and bonus). It is also used as a tool to align Galecto's strategic interests with those of the company's shareholders. Shares issued to employees are usually subject to a vesting period before they are earned and sold.
Galecto Quarterly Liabilities And Stockholders Equity |
|
Galecto Insider Trades History
Roughly 4.0% of Galecto are currently held by insiders. Unlike Galecto's institutional investors, corporate insiders most likely have a limit on the maximum percentage of share ownership. This is done to align insiders' influence against Galecto's private investors even though both sides will benefit from rising prices or experience loss when the share price declines. The good rule to have in mind is that the maximum share ownership percentage of the corporate insiders should not surpass 25%. View all of Galecto's insider trades
Galecto Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Galecto is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Galecto backward and forwards among themselves. Galecto's institutional investor refers to the entity that pools money to purchase Galecto's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Citigroup Inc | 2025-09-30 | 43.0 | Sbi Securities Co Ltd | 2025-09-30 | 18.0 | Susquehanna International Group, Llp | 2025-09-30 | 0.0 | Novo A/s | 2025-12-31 | 0.0 | Renaissance Technologies Corp | 2025-12-31 | 0.0 | Two Sigma Investments Llc | 2025-12-31 | 0.0 | Fmr Inc | 2025-12-31 | 238.9 K | Jain Global Llc | 2025-12-31 | 120.6 K | Boothbay Fund Management, Llc | 2025-12-31 | 95.8 K | Connective Capital Management Llc | 2025-09-30 | 27 K | Vanguard Group Inc | 2025-12-31 | 18.2 K |
Galecto Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Galecto insiders, such as employees or executives, is commonly permitted as long as it does not rely on Galecto's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Galecto insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Galecto Outstanding Bonds
Galecto issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Galecto uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Galecto bonds can be classified according to their maturity, which is the date when Galecto has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| ADGLXY 2625 31 MAR 36 Corp BondUS36321PAB67 | View | |
| ADGLXY 216 31 MAR 34 Corp BondUS36321PAD24 | View | |
| ADGLXY 294 30 SEP 40 Corp BondUS36321PAE07 | View | |
| MPLX LP 4125 Corp BondUS55336VAK61 | View |
Galecto Corporate Filings
13A | 17th of February 2026 The form used by investors holding more than 5% of a company's stock, to report their beneficial ownership pursuant to Rule 13d-1 or Rule 13d-2 under the Securities Exchange Act of 1934 | ViewVerify |
F4 | 12th of February 2026 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
| 11th of February 2026 Other Reports | ViewVerify | |
8K | 10th of February 2026 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
Pair Trading with Galecto
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Galecto position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Galecto will appreciate offsetting losses from the drop in the long position's value.Moving against Galecto Stock
| 0.52 | OSE | OSE Pharma SA | PairCorr |
| 0.48 | VCYT | Veracyte | PairCorr |
| 0.44 | RAC | Race Oncology | PairCorr |
| 0.38 | VCEL | Vericel Corp Ord | PairCorr |
| 0.33 | OB3 | OPTIBIOTIX HLTH PLC | PairCorr |
The ability to find closely correlated positions to Galecto could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Galecto when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Galecto - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Galecto to buy it.
The correlation of Galecto is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Galecto moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Galecto moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Galecto can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Galecto. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. To learn how to invest in Galecto Stock, please use our How to Invest in Galecto guide.You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.
Will Biotechnology sector continue expanding? Could Galecto diversify its offerings? Factors like these will boost the valuation of Galecto. Market participants price Galecto higher when confident in its future expansion prospects. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Galecto data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
The market value of Galecto is measured differently than its book value, which is the value of Galecto that is recorded on the company's balance sheet. Investors also form their own opinion of Galecto's value that differs from its market value or its book value, called intrinsic value, which is Galecto's true underlying value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Because Galecto's market value can be influenced by many factors that don't directly affect Galecto's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Galecto's value and its price as these two are different measures arrived at by different means. Investors typically determine if Galecto is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Meanwhile, Galecto's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.